🔖
Cite This Article
PARK, J. K., LEE, S. M. (2022). Desvenlafaxine Extended-Release in Panic Disorder: A Retrospective Chart Review. Alpha psychiatry (Online), Cilt: 23 - Sayı: 3, 142–143. https://ajindex.com/articles/434668
Journals / Alpha psychiatry (Online) / 2022 / Cilt: 23 - Sayı: 3
Desvenlafaxine Extended-Release in Panic Disorder: A Retrospective Chart Review
- Journal
- Alpha psychiatry (Online)
- Pages
- 142–143
- Publication Date
- 2022-10-12
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (5)
- Bradwejn J, Ahokas A, Stein DJ, Salinas E, Emilien G, Whitaker T. Venlafaxine extended-release capsules in panic disorder: flexible-dose, double- blind, placebo-controlled study. Br J Psychiatry. 2005
- [CrossRef] 2. Coleman KA, Xavier VY, Palmer TL, Meaney JV, Radalj LM, Canny LM. An indirect comparison of the efficacay and safety of desvenlafaxine and venlafaxine using palcebo as th common comparator. CNS Spectr. 2012
- 17(3):131-141. [CrossRef] 3. Kelly PJ. Calculating clinically significant change: application of the Clinical Global Impressions (CGI) Scale to evaluate client outcomes in private practice. Clin Psychol. 2010
- 14(3):107-111. [CrossRef] 4. Lieberman DZ, Montgomery SA, Tourian KA, et al. A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. Int Clin Psychopharmacol. 2008
- 23(4):188-197. [CrossRef] 5. Pristiq extended-release- desvenlafaxine succinate tablet, extended release [internet]. Available at: http: //lab eling.pfiz er.co m/sho wlabe ling. aspx? id=49 7.